Blood Transfusions Save Lives of Anemic Heart Attack Patients

Blood transfusions for anemic heart attack patients may reduce recurrent heart attacks and save lives.

Blood transfusion to anemic patients who have experienced heart attacks could help save their lives.

The study published in NEJM Evidence has found that anemic patients who received less blood were more likely to experience recurrent heart attacks with high mortality rates.

Calculate Your Lifetime Risk of Heart Attack
Heart Risk Calculator assesses the lifetime risk for a heart attack and helps in making the right lifestyle choices to protect your heart.

‘More blood transfusions in anemic #heartattack patients reduced the risk of death or recurrent heart attack by 2.4%. #anemia #medindia’

Blood Transfusions and Heart Attack Risks in Anemic Patients

Jeffrey L. Carson, provost and Distinguished Professor of medicine at Rutgers Robert Wood Johnson Medical School, led both studies. The 2023 trial – referred to as MINT (myocardium infarction and transfusion) – looked at transfusions in anemic patients following a heart attack. After that 2023 trial, Carson planned a study on blood transfusions that combined data from similar trials to generate more precise estimates of treatment effects.

In cooperation with researchers in France and the United States, Carson acquired data from the four clinical trials evaluating blood transfusion in 4,311 patients with heart attacks. These trials included patients who had a heart attack and low blood count. Half the patients received fewer blood transfusions and the other half received more blood transfusions. The trials compared the frequency of death at 30 days or recurrent heart attacks and death at six months.

The results of this analysis, published recently in NEJM Evidence, didn’t definitively establish that giving fewer blood transfusions increased a patient’s risk of death or heart attack at 30 days, but did suggest that using fewer transfusions was associated with an increased risk of death at six months.

Aplastic Anemia - Causes Symptoms Diagnosis Treatment Prognosis
Aplastic anemia (AA) is a term that refers to a condition where the body fails to produce enough blood cells.

How Blood Transfusions Save Lives

In the original clinical trial, a large percentage of patients had suffered a previous heart attack, heart failure, diabetes, or kidney disease. The average age of participants was 72, with 45% women.

The researchers compared the frequency of the main outcome of death or recurrent heart attack 30 days after enrollment into the trial. Although not statistically significant, the study found the frequency of mortality or recurrent heart attack was 2.4% lower when a liberal approach was used.

Anemia in Pregnancy - Causes Prevention Symptoms Diagnosis Treatment
Anemia is the commonest blood disorder that may occur in pregnancy and is usually due to low iron or folate reserves of the body and this is reflected as anemia.

“The results of this analysis show that giving more blood to anemic patients with heart attacks can save lives at six months,” Carson said. Both studies were funded by the National Heart, Lung, and Blood Institute, which is a part of the National Institutes of Health.

For nearly two decades, Carson has studied the implications of red blood cell transfusion strategies toward providing optimal treatment for patients. His work helped establish transfusion guidelines in 2012 used by physicians to inform patient care, updates to which were announced last year in the Journal of the American Medical Association emphasizing an individualized approach in adults and children that account for the patients underlying medical problems, patient preferences and symptoms.

Hearing Loss is Linked to Iron Deficiency Anemia
Iron deficiency anemia is prevalent in those with hearing loss due to damage in the outer ear, middle ear and hearing loss due to malfunction of the cochlea.

Source-Eurekalert